别名:PLN; PLB; Cardiac phospholamban; PLB应用:WB
反应种属:Human,Mouse
规格:50μl/100μl
| Description |
|---|
| Reversibly inhibits the activity of ATP2A2 in cardiac sarcoplasmic reticulum by decreasing the apparent affinity of the ATPase for Ca2+. Modulates the contractility of the heart muscle in response to physiological stimuli via its effects on ATP2A2. Modulates calcium re-uptake during muscle relaxation and plays an important role in calcium homeostasis in the heart muscle. The degree of ATP2A2 inhibition depends on the oligomeric state of PLN. ATP2A2 inhibition is alleviated by PLN phosphorylation. |
| Specification | |
|---|---|
| Aliases | PLN; PLB; Cardiac phospholamban; PLB |
| Entrez GeneID | 5350 |
| Swissprot | P26678 |
| WB Predicted band size | Calculated MW: 6 kDa; Observed MW: 12,24 kDa |
| Host/Isotype | Rabbit IgG |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human,Mouse |
| Immunogen | A synthetic phosphopeptide corresponding to residues surrounding Ser16 of human Phospholamban |
| Formulation | 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA |
| Application | |
|---|---|
| WB | 1/500-1/1000 |
![]() |
Western blot analysis of Phospho-lamban (Phospho-Ser16) in mouse heart lysates using Phospho-Phospho-lamban (Ser16) antibody. |
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
暂无评论
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
中文

发表回复